Nanograb is building the future of AI-powered targeted gene delivery.
Founders · Product
- Founded
- 2023
- Team
- 5 people
Browser storage is unavailable. Keep this page open and export your collection before leaving.
Explore
19 businesses
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
- Founded
- 2025
- Team
- 4 people
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
- Founded
- 2024
- Team
- 15 people
Atlas Discovery is an AI-native pharma company. Our biomedical AI agents connect existing knowledge to identify drug-rescue opportunities for rare diseases.
Founders · How it works
- Founded
- 2026
- Team
- 3 people
BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside…
Founders · Product
- Founded
- 2025
- Team
- 9 people
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling…
Founders · Product
- Founded
- 2023
- Team
- 6 people
Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control…
Founders · Product
- Founded
- 2024
What if we made as many cancer drugs next year as we have in the last decade?
Founders · Product
- Founded
- 2025
- Team
- 4 people
abinitio bio is the AI-native operating platform for drug development and manufacturing.
Founders · Product · How it works
- Founded
- 2026
- Team
- 2 people
FinalDose is building a programmable, DNA-targeted therapeutic platform to eliminate cancer at its genetic root — one chassis, retargeted in days across the long tail of driver mutations.
Founders · Product
- Founded
- 2025
- Team
- 5 people
Spatial proteomics from H&E and multimodal patient data imputation. Lattice predicts spatially resolved protein-marker maps from routine H&E slides as virtual multiplex immunofluorescence (mIF) channels, transforming incomplete patient…
Founders · Product · How it works
- Founded
- 2025
- Team
- 2 people
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy…
Founders · Product
- Founded
- 2024
- Team
- 2 people
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.
Founders · Product
- Founded
- 2025
- Team
- 3 people
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents. Sourcing Agent: Mines public/private databases and unstructured global data to…
Founders · Origins · Product
- Founded
- 2025
- Team
- 4 people
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Founders
- Founded
- 2023
- Team
- 5 people
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
Founders · Product
- Founded
- 2024
- Team
- 2 people
Ligo Biosciences builds generative models and experimental systems for enzyme design.
Founders · Product
- Founded
- 2024
- Team
- 4 people
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver…
Founders · Product
- Founded
- 2024
- Team
- 8 people
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for clinical trials and predict disease progression.
Customers · Founders · Product · How it works
- Founded
- 2025
- Team
- 6 people